Athersys Inc Asset Turnover Ratio (ATHX), as of third quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Athersys Inc  (ATHX)
 

Athersys Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 30 2023, Athersys Inc has not recorded any assets.
Visit Athersys Inc Balance sheet

Within sector Athersys Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2023 compared to previous quarter at no. .

Asset Turnover Ratio Definition



ATHX Asset Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Asset Change -78.89 % -70.24 % -54.46 % -56.88 % -50.96 %
Y / Y Revenue Change - -97.88 % - -95.57 % -98.64 %
Asset Turnover Ratio (TTM) - 0.01 - 0.15 0.14
ATHX's Total Ranking # # # # #
Seq. Asset Change -29.1 % -47.39 % -22.66 % -26.82 % -0.05 %
Seq. Revenue Change - - - -50.77 % -97.19 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Assets at quarter ending Sep 30 2023
Motus Gi Holdings Inc   0.03 $ 0.364  Millions$ 12.528  Millions
Lumos Pharma Inc   0.03 $ 1.737  Millions$ 60.035  Millions
Anaptysbio Inc   0.03 $ 14.960  Millions$ 541.650  Millions
Relay Therapeutics Inc   0.03 $ 25.800  Millions$ 1,001.576  Millions
Scorpius Holdings inc   0.03 $ 2.227  Millions$ 86.504  Millions
Absci Corp  0.03 $ 6.937  Millions$ 276.828  Millions
Therapeutic Solutions International Inc   0.02 $ 0.084  Millions$ 3.529  Millions
Dbv Technologies S a   0.02 $ 5.550  Millions$ 234.539  Millions
Astrotech Corp  0.02 $ 1.137  Millions$ 48.262  Millions
Janux Therapeutics Inc   0.02 $ 8.467  Millions$ 361.329  Millions
Checkpoint Therapeutics inc   0.02 $ 0.171  Millions$ 7.435  Millions
Meiragtx Holdings Plc  0.02 $ 6.689  Millions$ 295.959  Millions
Nexalin Technology Inc   0.02 $ 0.129  Millions$ 5.743  Millions
Agios Pharmaceuticals Inc   0.02 $ 24.030  Millions$ 1,120.607  Millions
Vistagen Therapeutics Inc   0.02 $ 0.811  Millions$ 38.240  Millions
Q32 Bio Inc   0.02 $ 3.817  Millions$ 183.938  Millions
Anavex Life Sciences Corp   0.02 $ 2.743  Millions$ 156.022  Millions
Sonnet Biotherapeutics Holdings Inc   0.02 $ 0.148  Millions$ 8.651  Millions
Senti Biosciences Holdings Inc   0.02 $ 2.619  Millions$ 154.403  Millions
Atrium Therapeutics Inc   0.02 $ 10.136  Millions$ 609.181  Millions
Talis Biomedical Corporation  0.02 $ 2.196  Millions$ 133.162  Millions
Insight Molecular Diagnostics Inc   0.02 $ 1.441  Millions$ 88.005  Millions
One World Products Inc   0.02 $ 0.052  Millions$ 3.229  Millions
Vivos Inc  0.02 $ 0.026  Millions$ 1.640  Millions
Marizyme Inc   0.02 $ 0.591  Millions$ 37.715  Millions
Bridgebio Pharma Inc   0.02 $ 9.428  Millions$ 601.846  Millions
Omega Therapeutics Inc   0.02 $ 2.840  Millions$ 187.286  Millions
Celldex Therapeutics inc   0.01 $ 4.365  Millions$ 314.205  Millions
Inhibikase Therapeutics Inc   0.01 $ 0.324  Millions$ 23.332  Millions
Clene Inc   0.01 $ 0.718  Millions$ 53.165  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.